Received Dec 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z010729 | OT |
No additional AEs or PQC reported.; PROQUAD was administered to a 16 year old patient.; This spontaneous report was received from a Nurse and refers to a 16-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Dec-2025, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot #Z010729, expiration date: 22-Dec-2026, 0.5 mL, administered by Intramuscular route (strength, dose number, and anatomical location were not provided) (Inappropriate age at vaccine administration) No adverse event reported.
Sterile diluent